NSE · JYOTHYLAB
Jyothy Labs Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹717 Cr with net profit ₹68 Cr — a 9.41% net margin, versus 10.97% the period before.
Shareholding
As of 2026-06-30
- Promoter62.89%
- Public11.61%
- FII12.13%
- DII13.37%
2,47,104 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.88× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Personal Care - Indian · ranked #6 of 14 by market cap · medians across 12 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Godrej Consumer Products Ltd. | ₹1,10,040 Cr | 243.3 | 8.7 | 14.71% | 12.16% |
| Lenskart Solutions Ltd. | ₹96,308 Cr | 473.42 | 11.01 | 5.65% | 5.6% |
| Dabur India Ltd. | ₹76,670 Cr | 207.79 | 6.71 | 16.59% | 14.36% |
| Cupid Limited | ₹31,317 Cr | 862.59 | 69.47 | 24.01% | 30.26% |
| Emami Limited | ₹17,787 Cr | 124.24 | 6.08 | 26.51% | 20.51% |
| Jyothy Labs Limited(this company) | ₹7,575 Cr | 112.11 | 4.77 | 18.07% | 13.01% |
| Bajaj Consumer Care Ltd. | ₹7,014 Cr | 113.05 | 9.29 | 25.19% | 16.49% |
| Radix Industries (India) Ltd. | ₹225 Cr | 77 | 9.67 | 13.72% | 6.41% |
| Thrive Future Habitats Limited | ₹94 Cr | — | 1.78 | -1.94% | -85.25% |
| JHS Svendgaard Laboratories Ltd. | ₹66 Cr | — | 0.38 | -1.1% | -1.89% |
AI analysis
AI-generated · google/gemini-2.5-flashJyothy Labs Limited is listed with a market capitalization of Rs 7384 Cr. The company reported revenue of Rs 3011.85 Cr and a profit margin of 13.01%. Diluted EPS stands at Rs 9.97.
Positives
- +The company maintains a low debt-to-equity ratio of 0.03.
- +Return on capital employed (ROCE) is 23.40%, indicating efficient capital utilization.
- +Promoter holding is at 62.8882% as of June 30, 2026, which may suggest confidence in the business.
- +Profit margin is 13.01%.
Negatives
- −Revenue growth for the company is 3.3%, which indicates a modest increase.
- −The Price-to-Earnings (PE) ratio is 109.28, which is high.
- −Quarterly net profit experienced a decline from Rs 104.99 Cr in Sept 2024 to Rs 76.3 Cr in Mar 2025.
Financial Performance
Jyothy Labs Limited documented a revenue of Rs 3011.85 Cr, reflecting a revenue growth of 3.3%. The company's annual revenue for the year ending Mar 2025 was Rs 2902.56 Cr, with a net profit of Rs 370.43 Cr. Quarterly revenue for Mar 2026 was Rs 717.41 Cr, generating a net profit of Rs 67.52 Cr.
Profitability & Returns
The company’s profit margin is 13.01%. Return on equity (ROE) is 18.07%, and return on capital employed (ROCE) is 23.40%. The diluted EPS for the period stands at Rs 9.97.
Balance Sheet
The debt-to-equity ratio is 0.03, indicating a low level of debt relative to equity. The book value per share is Rs 55.81.
Ownership & Pledges
As of June 30, 2026, promoters held 62.8882% of the company's shares. Foreign Institutional Investors (FIIs) held 12.1297%, and Domestic Institutional Investors (DIIs) held 13.3735%. The public shareholding was 11.6086%. There are no promoter pledges reported for the latest period.
Data as of — price: 2026-07-29 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.